Patents by Inventor Maya Haus-Cohen

Maya Haus-Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti human immunodeficiency antibodies and uses thereof
    Patent number: 8747855
    Abstract: Provided are antibodies comprising an antigen recognition domain capable of binding an MHC molecule being complexed with a human immunodeficiency virus (HIV) peptide, wherein the antibody does not bind the MHC molecule in an absence of the complexed peptide, and wherein the antibody does not bind the peptide in an absence of the MHC molecule. Also provided are methods of using same for diagnosing HIV infection and treating AIDS.
    Type: Grant
    Filed: April 5, 2009
    Date of Patent: June 10, 2014
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Yoram Reiter, Maya Haus-Cohen
  • ANTI HUMAN IMMUNODEFICIENCY ANTIBODIES AND USES THEREOF
    Publication number: 20110020357
    Abstract: Provided are antibodies comprising an antigen recognition domain capable of binding an MHC molecule being complexed with a human immunodeficiency virus (HIV) peptide, wherein the antibody does not bind the MHC molecule in an absence of the complexed peptide, and wherein the antibody does not bind the peptide in an absence of the MHC molecule. Also provided are methods of using same for diagnosing HIV infection and treating AIDS.
    Type: Application
    Filed: April 5, 2009
    Publication date: January 27, 2011
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Yoram Reiter, Maya Haus-Cohen
  • ANTIBODIES, METHODS AND KITS FOR DIAGNOSING AND TREATING MELANOMA
    Publication number: 20100158927
    Abstract: A method of diagnosing melanoma and antibodies capable of same are disclosed. The method comprises contacting a cell of the subject with an antibody comprising an antigen recognition domain capable of binding to an MHC-I molecule being complexed with a tyrosinase peptide, wherein the antibody does not bind the MHC-I in the absence of the complexed peptide, and wherein the antibody does not bind the peptide in an absence of the MHC, under conditions which allow immunocomplex formation, wherein a presence of the immunocomplex or level thereof is indicative of the melanoma. Methods for treating melanoma and antibodies capable of same are also disclosed. Pharmaceutical compositions comprising antibodies are also disclosed.
    Type: Application
    Filed: March 27, 2008
    Publication date: June 24, 2010
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Yoram Reiter, Cyril Cohen, Eynav Klechevsky, Yael Michaeli, Maya Haus-Cohen, Galit Denkberg
  • Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
    Patent number: 7294701
    Abstract: An antibody fragment and methods of utilizing same are provided. The antibody fragment includes an antigen binding region capable of binding an extracellular portion of a P-glycoprotein thereby at least partially inhibiting drug efflux activity in multidrug resistant cells.
    Type: Grant
    Filed: April 2, 2003
    Date of Patent: November 13, 2007
    Assignee: Technion Research & Development Foundation Ltd.
    Inventors: Yoram Reiter, Maya Haus-Cohen
  • Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
    Publication number: 20040197334
    Abstract: An antibody fragment and methods of utilizing same are provided. The antibody fragment includes an antigen binding region capable of binding an extracellular portion of a P-glycoprotein thereby at least partially inhibiting drug efflux activity in multidrug resistant cells.
    Type: Application
    Filed: April 2, 2003
    Publication date: October 7, 2004
    Applicant: Technion Research & Development Foundation Ltd.
    Inventors: Yoram Reiter, Maya Haus-Cohen